NUTX nutexhealth.com: Forward Price-to-Revenue Multiple

Corporate emblem and logo of Nutex Health (NUTX)

Steady demand for emergency care provides Nutex Health Inc. (NUTX) with a consistent cash flow. The forward P/S ratio demonstrates multiplier volatility amid changing tax conditions, where 1.30 captures the current value of the indicator. The network's profitability depends on the insurance structure and medical staff, however, the expansion of large healthcare behemoths and the revision of payment terms create serious risks for revenue.

NUTX (nutexhealth.com) Forward Price to Sales history from 04/28/2023 to 11/13/2026

NUTX (Nutex Health Hospitals): analytical breakdowns and indicator data

- current price and projected stock value:
Stock Price Nutex Health|NUTX - Average Forecast Price
- company stock capitalization data:
Market Valuation Nutex Health Hospitals|NUTX - Business Value
- business book valuation details:
Accounting Value per Share Nutex Health|NUTX - Accounting Value of Company|Market Capitalization to Book Value Ratio nutexhealth.com|NUTX - Aggregate Asset Value
- company total debt and liquidity indicators:
Total Debt to Capital Nutex Health Inc.|NUTX - Long-Term Liabilities to Capital|Short-Term Debt to Capital Nutex Health Inc.|NUTX - Company Aggregate Debts|Debt to Book Capitalization Ratio Nutex Health Hospitals|NUTX - Company Long-Term Debt|Company Current Liabilities Nutex Health|Quick Ratio nutexhealth.com
- net income and valuation multiples indicators:
NUTX - Final Profit|Future Profit Nutex Health Inc.|NUTX - Company Value to Net Income|Forward P/E Multiple Nutex Health Corp|NUTX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nutex Health Hospitals|NUTX - Operating profit before amortization|Net earnings per share (EPS TTM) Nutex Health|NUTX - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months nutexhealth.com|NUTX - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Nutex Health Inc.
- company sales and revenue statistics:
NUTX - Company Sales Volume|Company Future Sales Volume Nutex Health|NUTX - P/S Multiple|Forward Price-to-Revenue Multiple Nutex Health Hospitals
Fundamental company analysis:NUTX (Nutex Health)
Product sample of Nutex Health Hospitals

The forward P/S ratio determines the relationship between the current market value of Nutex Health Inc. (NUTX) and expected sales volume, revealing the extent of the asset's overvaluation. For the issuer, this coefficient reflects market confidence in the monetization of cloud IT platforms and patient routing systems. By analyzing the projected P/S of Nutex Health Inc. (NUTX), an investor can assess the stability of the capitalization amid the evolutionary expansion of the micro-hospital network. The stability of this metric confirms the fundamental balance of the business valuation.

Who Nutex Health Inc. competes with

Forward P/S Multiple HCA (HCA Healthcare)|Tenet Healthcare Corp (THC) - Market Cap to Future Revenue Ratio|FMS: Forward Price-to-Revenue Multiple|SOLV (Solventum Health) - Market Cap to Projected Revenue|EHC (Encompass Health) - Forward Price-to-Revenue Multiple|Universal Health Services, Inc. - Forward Price to Sales|DVA (DaVita) - Forward P/S Multiple|RDNT: Forward Price to Sales|Forward P/S Multiple OPCH|SGRY - Market Cap to Future Revenue Ratio|Forward P/S Multiple PINC (Premier, Inc.)|Forward P/S Multiple nationalvision.com EYE|PGNY - Price-to-Projected Revenue Ratio|ARDT: Price-to-Projected Revenue Ratio|SEM (Select Medical Corp) - Forward Price-to-Revenue Multiple|ASTH: Price to Expected Revenue Ratio|MD (Pediatrix Corp) - Forward P/S Multiple|USPH: Forward Price to Sales|Forward Price-to-Revenue Multiple PNTG (The Pennant Group)|ORGO (Organogenesis Holdings Inc.) - Forward Price to Sales|Forward P/S Multiple AUNA (Auna Health)|Market Cap to Expected Sales Ratio SBC Medical Group Holdings (SBC)|EOLS - Price-to-Projected Revenue Ratio|CYH (chs.net) - Market Cap to Projected Revenue|SKIN: Forward P/S Multiple|Forward Price-to-Revenue Multiple MediWound|Forward Price-to-Revenue Multiple BTMD|The Joint (JYNT) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio DocGo Inc. (DCGO)|p3hp.org - Market Cap to Projected Revenue|Gain Therapeutics - Forward Price-to-Revenue Multiple|Forward P/S Multiple EUDA Health Holdings EUDA|BMGL: Forward Price-to-Revenue Multiple|CollPlant Biotechnologies - Price to Expected Revenue Ratio|CUPR (Cuprina Holdings (Cayman) Ltd) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue CCM|Forward Price-to-Revenue Multiple AMS|MRM (MEDIROM Healthcare Group Inc.) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio Avalon GloboCare (ALBT)|DHAI (DIH Group) - Forward Price to Sales|Forward P/S Multiple XAGE (Longevity Health Holdings)|newgenivf.com (NIVF) - Market Cap to Future Revenue Ratio|ATI Physical Therapy Corp - Forward P/S Multiple|CMAX - Forward P/S Multiple|KDLY (Kindly MD Corp) - Forward Price-to-Revenue Multiple|MODV: Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio Novo Integrated Sciences|Forward Price-to-Revenue Multiple SunLink Health Systems, Inc (SSY)|Forward P/S Multiple BACK